5UM Stock Overview
Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People’s Republic of China.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 3/6 |
Financial Health | 3/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
Genertec Universal Medical Group Company Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.47 |
52 Week High | HK$0.59 |
52 Week Low | HK$0.40 |
Beta | 0.72 |
1 Month Change | -3.72% |
3 Month Change | -1.27% |
1 Year Change | -14.50% |
3 Year Change | -27.75% |
5 Year Change | -40.18% |
Change since IPO | -38.36% |
Recent News & Updates
Recent updates
Shareholder Returns
5UM | DE Diversified Financial | DE Market | |
---|---|---|---|
7D | -0.4% | 2.8% | 1.4% |
1Y | -14.5% | 5.4% | 7.5% |
Return vs Industry: 5UM underperformed the German Diversified Financial industry which returned 0.1% over the past year.
Return vs Market: 5UM underperformed the German Market which returned 5.5% over the past year.
Price Volatility
5UM volatility | |
---|---|
5UM Average Weekly Movement | 8.9% |
Diversified Financial Industry Average Movement | 3.8% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 5UM has not had significant price volatility in the past 3 months.
Volatility Over Time: 5UM's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1984 | 20,048 | Wang Wenbing | https://www.umcare.cn |
Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People’s Republic of China. It operates in two segments, Finance Business and Hospital Group Business. The Finance Business segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services.
Genertec Universal Medical Group Company Limited Fundamentals Summary
5UM fundamental statistics | |
---|---|
Market cap | €944.48m |
Earnings (TTM) | €242.43m |
Revenue (TTM) | €1.60b |
3.9x
P/E Ratio0.6x
P/S RatioIs 5UM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
5UM income statement (TTM) | |
---|---|
Revenue | CN¥12.53b |
Cost of Revenue | CN¥8.46b |
Gross Profit | CN¥4.06b |
Other Expenses | CN¥2.17b |
Earnings | CN¥1.89b |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Mar 27, 2024
Earnings per share (EPS) | 1.00 |
Gross Margin | 32.42% |
Net Profit Margin | 15.12% |
Debt/Equity Ratio | 261.4% |
How did 5UM perform over the long term?
See historical performance and comparison